Plasma Neurofilament Light Is Not Associated with Ongoing Neuroaxonal Injury or Cognitive Decline in Perinatally HIV Infected Adolescents: A Brief Report.
HIV
NfL
brain structure
cognitive performance
neuroaxonal injury
pathogenesis
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
24 03 2022
24 03 2022
Historique:
received:
16
02
2022
revised:
13
03
2022
accepted:
21
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
Despite combination antiretroviral therapy (cART), adolescents with perinatally acquired human immunodeficiency virus (PHIV) exhibit cerebral injury and cognitive impairment. Plasma neurofilament light (pNfL) is a biomarker identified as a promising marker associated with neuroaxonal injury and cognitive impairment. To investigate whether cerebral injury in cART-treated PHIV adolescents is persistent, we longitudinally measured pNfL. We included 21 PHIV adolescents and 23 controls, matched for age, sex, ethnic origin and socio-economic status. We measured pNfL in both groups and CSF NfL in PHIV adolescents using a highly sensitive Single Molecule Array (Simoa) immunoassay. We compared pNfL between groups over time with a mean follow-up time of 4.6 years and assessed its association with MRI outcomes, cognitive function and HIV-related characteristics using linear mixed models. The median age was 17.5 years (15.5-20.7) and 16.4 years (15.8-19.6) at the second assessment for PHIV adolescents and controls, respectively. We found comparable pNfL (PHIV vs. controls) at the first (2.9 pg/mL (IQR 2.0-3.8) and 3.0 pg/mL (IQR 2.3-3.5),
Identifiants
pubmed: 35458401
pii: v14040671
doi: 10.3390/v14040671
pmc: PMC9030750
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Neurovirol. 2018 Dec;24(6):695-701
pubmed: 30105502
AIDS Rev. 2021 Mar 18;23(4):167-185
pubmed: 33735910
Neurology. 2019 Sep 3;93(10):e968-e974
pubmed: 31383792
Medicine (Baltimore). 2016 Mar;95(12):e3093
pubmed: 27015179
J Neurol. 2019 Sep;266(9):2129-2136
pubmed: 31123861
Clin Infect Dis. 2015 Apr 1;60(7):1111-9
pubmed: 25516183
Curr Top Behav Neurosci. 2021;50:147-174
pubmed: 31522375
J Infect Dis. 2015 Dec 1;212(11):1759-67
pubmed: 25995196
Curr Infect Dis Rep. 2017 Nov 21;19(12):50
pubmed: 29164407
Sci Rep. 2019 May 29;9(1):8004
pubmed: 31142789
Neurology. 2021 Nov 9;97(19):e1898-e1905
pubmed: 34504023
AIDS. 2021 Jul 1;35(8):1221-1228
pubmed: 33710018
Pediatrics. 2018 Feb;141(2):
pubmed: 29374109
J Leukoc Biol. 2018 Apr;103(4):671-680
pubmed: 29377283
AIDS. 2019 Dec 1;33(15):2363-2374
pubmed: 31764101
Ann Clin Transl Neurol. 2020 Jan;7(1):139-143
pubmed: 31893563
J Neurovirol. 2015 Aug;21(4):439-48
pubmed: 25776526
Neurol Clin Pract. 2019 Oct;9(5):433-442
pubmed: 31750029
Front Neurosci. 2021 Mar 25;15:654942
pubmed: 33841093
Antivir Ther. 2017;22(8):669-680
pubmed: 28327462
Paediatr Drugs. 2020 Oct;22(5):511-524
pubmed: 32936413
Neurology. 2007 Oct 9;69(15):1536-41
pubmed: 17923616
Appl Neuropsychol Child. 2018 Jul-Sep;7(3):277-285
pubmed: 28426248
Front Neurol. 2020 Oct 23;11:562510
pubmed: 33192996
Expert Rev Mol Diagn. 2017 Aug;17(8):761-770
pubmed: 28598205
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
PLoS One. 2014 Feb 11;9(2):e88591
pubmed: 24523921
Neurodegener Dis. 2018;18(2-3):165-172
pubmed: 29898446
AIDS. 2009 Sep 10;23(14):1893-901
pubmed: 19644348
AIDS. 2021 Jul 15;35(9):1375-1384
pubmed: 33710019
AIDS. 2015 Jan 28;29(3):253-61
pubmed: 25426811
Rev Med Virol. 2014 Sep;24(5):316-31
pubmed: 24806816
Br J Psychiatry. 2009 Sep;195(3):249-56
pubmed: 19721116
Clin Infect Dis. 2020 Mar 17;70(7):1364-1371
pubmed: 31106812